Detalles de la búsqueda
1.
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study.
Br J Haematol
; 193(5): 906-914, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33948942
2.
Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome.
Acta Oncol
; 58(8): 1170-1177, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31131659
3.
Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
Ann Hematol
; 97(11): 2129-2135, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30091025
4.
Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma.
Cardiooncology
; 7(1): 6, 2021 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33536059
5.
Successful intraperitoneal rituximab treatment in a patient with therapy-resistant malignant ascites due to mantle cell lymphoma.
Ann Hematol
; 94(10): 1757-8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26155910
6.
Validation and optimization of a predictive model for radiation pneumonitis in patients with lung cancer.
Oncol Lett
; 12(2): 1144-1148, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27446409
7.
Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature-based meta-analysis of randomized studies.
Lung Cancer
; 84(3): 209-14, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24702946
Resultados
1 -
7
de 7
1
Próxima >
>>